Contrafect Corp (CFRX)

[trickledownfacists]

ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced that Roger J. Pomerantz, M.D., F.A.C.P., President, Chief Executive Officer, and Chairman of ContraFect, will deliver the keynote address to open Maxim’s Infectious Disease Virtual Conference to be held on May 5, 2020. Dr. Pomerantz will discuss the urgent need for new antimicrobials and the medical attributes required to provide the basis for a renaissance in the anti-infectives sector. Dr. Pomerantz will also virtually present the Company’s portfolio and platform technology of DLAs during a panel discussion of “Non-antibiotic Anti-infectives.”
Keynote Presentation Details:

Keynote Presentation Title: The Rise of Antimicrobials
Time and Date: Tuesday, May 5, 2020, 10:00 a.m. ET

Panel Discussion Details:

Panel Session Title: Non-antibiotic Anti-infectives
Time and Date: Tuesday, May 5, 2020, 10:30 a.m. ET